Pediatric Rheumatologist Dr. Eyal Muscal recently served as a co-director for the inaugural International Pediatric Autoimmune Encephalitis Treatment Consensus Meeting.
Held in November at the Carnegie Endowment for International Peace in Washington, D.C., this meeting brought together pediatric experts from around North America to work on achieving a number of goals for children with this rare immune condition.
Goals included the standardization of diagnosis, as well as the development of treatment roadmaps, among other topics. Along with meeting co-directors from Duke and DC children’s hospitals Muscal will spearhead the development of consensus treatment plans for autoimmune encephalitides.
Muscal is a pediatric rheumatologist with a Master’s of Science Degree in clinical research whose activities include patient care, fellowship education and clinical research. His research interests include neurologic manifestation of systemic autoimmune disorders (primarily SLE, APS, vasculitis, and autoimmune encephalitis). His interest in immuno-neurology has led to a secondary appointment in the child neurology division at Baylor College of Medicine.
Muscal has received grant funding and research awards for pilot research studies. He is also the pediatric rheumatology program director and recent co-lead of a national pediatric rheumatology mentoring project. Muscal is involved in Texas Children’s Pediatrics Fellows’ College.